BCYC Q2 2020 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$360M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+3.2% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$13M-801.0% margin

Net Income

-$12M-771.2% margin

EPS (Diluted)

$-0.67

QoQ Revenue Growth

+39.1%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$13M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$119M

Total Liabilities

$48M

Stockholders' Equity

$71M

Cash & Equivalents

$97M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+3.2%
Gross Profit	$2M	-$5M	+131.3%
Operating Income	-$13M	-$8M	-57.5%
Net Income	-$12M	-$10M	-18.6%